Aller au contenu principal
Fermer

Transgene to Participate in Upcoming Investor Meetings
information fournie par Boursorama CP 17/12/2025 à 17:45

Transgene to Participate in Upcoming Investor Meetings


Strasbourg (France), December 17, 2025, 17:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional investors during the upcoming editions of:

- LifeSci Partners Corporate Access Event (by LifeSci Partners), on January 12 and 13, 2026, in San Francisco (United States) in conjunction with the JP Morgan Healthcare Conference;
- Biomed Forum (by Allinvest Securities), on January 29, 2026, in Paris (France).

Valeurs associées

0,7520 EUR Euronext Paris 0,00%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

valeur

dernier

var.

80,38 +1,41%
25,4 0,00%
8 421,14 -0,55%
Or
4 156,56 0,00%
185 -3,56%
Chargement...